Overview

A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety of YM543 in type 2 Diabetes Mellitus patients and to investigate whether this study drug is effective in these patients
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Metformin